The global green tea supplements market is valued at US$6.70 billion in 2026 and is projected to reach US$10.21 billion by 2033, growing at a CAGR of 6.2%, driven by rising demand for EGCG-based metabolic health and weight management supplements.
Growth is driven by increasing use of green tea catechins in metabolic health and oncology research, along with expanding adoption of green tea extracts in cosmetic and personal care products.
The Capsule segment leads with 48.0% market share due to precise dosing, product stability, and strong acceptance across pharmacy and healthcare channels.
North America leads with 35.0% market share, supported by favorable supplement regulations, strong retail networks, and high consumer awareness of preventive health products.
Key opportunities lie in pharmaceutical-grade EGCG ingredient supply for clinical research and chronic disease management applications.